Halbert Hargrove Global Advisors, LLC Bristol Myers Squibb CO Transaction History

Halbert Hargrove Global Advisors, LLC

  • $1.81 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023
BUY
$65.71 - $74.53 $35,549 - $40,320
541 Added 14.97%
4,156 $288,000
Q4 2022

Jan 25, 2023
SELL
$68.48 - $81.09 $23,214 - $27,489
-339 Reduced 8.57%
3,615 $0
Q2 2022

Aug 05, 2022
BUY
$72.62 - $79.98 $14,088 - $15,516
194 Added 5.16%
3,954 $304,000
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $231,164 - $277,187
3,760 New
3,760 $275,000
Q4 2021

Feb 14, 2022
SELL
$53.63 - $62.52 $201,166 - $234,512
-3,751 Closed
0 $0
Q3 2021

Oct 29, 2021
SELL
$59.17 - $69.31 $12,307 - $14,416
-208 Reduced 5.25%
3,751 $222,000
Q2 2021

Jul 29, 2021
BUY
$61.91 - $67.42 $3,900 - $4,247
63 Added 1.62%
3,959 $265,000
Q1 2021

May 06, 2021
BUY
$59.34 - $66.74 $7,536 - $8,475
127 Added 3.37%
3,896 $246,000
Q4 2020

Feb 04, 2021
BUY
$57.74 - $65.43 $1,328 - $1,504
23 Added 0.61%
3,769 $234,000
Q3 2020

Nov 10, 2020
BUY
$57.43 - $63.64 $12,692 - $14,064
221 Added 6.27%
3,746 $226,000
Q2 2020

Aug 10, 2020
BUY
$54.82 - $64.09 $193,240 - $225,917
3,525 New
3,525 $207,000
Q1 2020

May 01, 2020
SELL
$46.4 - $67.43 $170,288 - $247,468
-3,670 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$49.21 - $64.19 $180,600 - $235,577
3,670 New
3,670 $236,000

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Halbert Hargrove Global Advisors, LLC Portfolio

Follow Halbert Hargrove Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email